Literature DB >> 10229714

Industrialization, electromagnetic fields, and breast cancer risk.

L I Kheifets1, C C Matkin.   

Abstract

The disparity between the rates of breast cancer in industrialized and less-industrialized regions has led to many hypotheses, including the theory that exposure to light-at-night and/or electromagnetic fields (EMF) may suppress melatonin and that reduced melatonin may increase the risk of breast cancer. In this comprehensive review we consider strengths and weaknesses of more than 35 residential and occupational epidemiologic studies that investigated the association between EMF and breast cancer. Although most of the epidemiologic data do not provide strong support for an association between EMF and breast cancer, because of the limited statistical power as well as the possibility of misclassification and bias present in much of the existing data, it is not possible to rule out a relationship between EMF and breast cancer. We make several specific recommendations for future studies carefully designed to test the melatonin-breast cancer and EMF-breast cancer hypotheses. Future study designs should have sufficient statistical power to detect small to moderate associations; include comprehensive exposure assessments that estimate residential and occupational exposures, including shift work; focus on a relevant time period; control for known breast cancer risks; and pay careful attention to menopausal and estrogen receptor status.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10229714      PMCID: PMC1566357          DOI: 10.1289/ehp.99107s1145

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  61 in total

1.  Mortality experience of electrical engineers.

Authors:  R Olin; D Vågerö; A Ahlbom
Journal:  Br J Ind Med       Date:  1985-03

2.  Re: "Risk of premenopausal breast cancer and use of electric blankets".

Authors:  R G Stevens
Journal:  Am J Epidemiol       Date:  1995-08-15       Impact factor: 4.897

3.  Secular trends in the distributions of the breast cancer risk factors--menarche, first birth, menopause, and weight--in Hiroshima and Nagasaki, Japan.

Authors:  D G Hoel; T Wakabayashi; M C Pike
Journal:  Am J Epidemiol       Date:  1983-07       Impact factor: 4.897

4.  Exposure to electromagnetic fields during pregnancy with emphasis on electrically heated beds: association with birthweight and intrauterine growth retardation.

Authors:  M B Bracken; K Belanger; K Hellenbrand; L Dlugosz; T R Holford; J E McSharry; K Addesso; B Leaderer
Journal:  Epidemiology       Date:  1995-05       Impact factor: 4.822

5.  Cancer morbidity among workers in the telecommunications industry.

Authors:  D Vågerö; A Ahlbom; R Olin; S Sahlsten
Journal:  Br J Ind Med       Date:  1985-03

6.  Melatonin inhibition and pinealectomy enhancement of 7,12-dimethylbenz(a)anthracene-induced mammary tumors in the rat.

Authors:  L Tamarkin; M Cohen; D Roselle; C Reichert; M Lippman; B Chabner
Journal:  Cancer Res       Date:  1981-11       Impact factor: 12.701

7.  Incidence of cancer in the electronics industry: using the new Swedish Cancer Environment Registry as a screening instrument.

Authors:  D Vågerö; R Olin
Journal:  Br J Ind Med       Date:  1983-05

8.  Occupational exposures and female breast cancer mortality in the United States.

Authors:  K P Cantor; P A Stewart; L A Brinton; M Dosemeci
Journal:  J Occup Environ Med       Date:  1995-03       Impact factor: 2.162

9.  Cancer mortality among workers in a thermoelectric power plant.

Authors:  G Cammarano; P Crosignani; F Berrino; G Berra
Journal:  Scand J Work Environ Health       Date:  1984-08       Impact factor: 5.024

10.  Mortality in workers exposed to electromagnetic fields.

Authors:  S Milham
Journal:  Environ Health Perspect       Date:  1985-10       Impact factor: 9.031

View more
  2 in total

Review 1.  Review of the epidemiologic literature on EMF and Health.

Authors:  I C Ahlbom; E Cardis; A Green; M Linet; D Savitz; A Swerdlow
Journal:  Environ Health Perspect       Date:  2001-12       Impact factor: 9.031

2.  The National Cancer Institute of Canada Clinical Trials Group MAP.3 trial: an international breast cancer prevention trial.

Authors:  H Richardson; D Johnston; J Pater; P Goss
Journal:  Curr Oncol       Date:  2007-06       Impact factor: 3.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.